![TPV TPV](https://data.pdbj.org/pdbjplus/data/cc/svg/TPV.svg) | TPV | 表記: | N-(3-{(1R)-1-[(6R)-4-HYDROXY-2-OXO-6-PHENETHYL-6-PROPYL-5,6-DIHYDRO-2H-PYRAN-3-YL]PROPYL}PHENYL)-5-(TRIFLUOROMETHYL)-2-PYRIDINESULFONAMIDE | 組成式: | C31 H33 F3 N2 O5 S | SMILES: | FC(F)(F)c1ccc(nc1)S(=O)(=O)Nc2cccc(c2)C(C=3C(=O)OC(CCC)(CC=3O)CCc4ccccc4)CC | InChi: | InChI=1S/C31H33F3N2O5S/c1-3-16-30(17-15-21-9-6-5-7-10-21)19-26(37)28(29(38)41-30)25(4-2)22-11-8-12-24(18-22)36-42(39,40)27-14-13-23(20-35-27)31(32,33)34/h5-14,18,20,25,36-37H,3-4,15-17,19H2,1-2H3/t25-,30-/m1/s1 | 別名: | TIPRANAVIR | 定義日: | 1999-10-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-(3-{(1R)-1-[(6R)-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-5,6-dihydro-2H-pyran-3-yl]propyl}phenyl)-5-(trifluoromethyl)pyridine-2-sulfonamide |
|
![RAB RAB](https://data.pdbj.org/pdbjplus/data/cc/svg/RAB.svg) | RAB | 表記: | 2-(6-AMINO-PURIN-9-YL)-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-3,4-DIOL | 組成式: | C10 H13 N5 O4 | SMILES: | n2c1c(ncnc1n(c2)C3OC(C(O)C3O)CO)N | InChi: | InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7+,10-/m1/s1 | 別名: | 9-BETA-D-ARABINOFURANOSYL-ADENINE | 定義日: | 2003-07-09 | 最終更新日: | 2021-03-01 | 識別子(ID): | 9-beta-D-arabinofuranosyl-9H-purin-6-amine |
|
![XN3 XN3](https://data.pdbj.org/pdbjplus/data/cc/svg/XN3.svg) | XN3 | 表記: | N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(BENZO[1,3]DIOXOL-5-YLMETHYL)-PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE | 組成式: | C38 H48 N4 O6 | SMILES: | O=C(NC2c1ccccc1CC2O)C(Cc3ccccc3)CC(O)CN4C(C(=O)NC(C)(C)C)CN(CC4)Cc5ccc6OCOc6c5 | InChi: | InChI=1S/C38H48N4O6/c1-38(2,3)40-37(46)31-23-41(21-26-13-14-33-34(18-26)48-24-47-33)15-16-42(31)22-29(43)19-28(17-25-9-5-4-6-10-25)36(45)39-35-30-12-8-7-11-27(30)20-32(35)44/h4-14,18,28-29,31-32,35,43-44H,15-17,19-24H2,1-3H3,(H,39,45)(H,40,46)/t28-,29+,31+,32-,35+/m1/s1 | 別名: | ANALOGUE OF INDINAVIR DRUG | 定義日: | 2001-11-02 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-4-(1,3-benzodioxol-5-ylmethyl)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]-N-tert-butylpiperazine-2-carboxamide (non-preferred name) |
|
![5TR 5TR](https://data.pdbj.org/pdbjplus/data/cc/svg/5TR.svg) | 5TR | 表記: | [(2~{E},6~{E},10~{E},14~{E},18~{Z},22~{E},26~{Z},30~{E},34~{E},38~{E})-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaenyl] dihydrogen phosphate | 組成式: | C55 H91 O4 P | SMILES: | CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCO[P](O)(O)=O | InChi: | InChI=1S/C55H91O4P/c1-45(2)23-13-24-46(3)25-14-26-47(4)27-15-28-48(5)29-16-30-49(6)31-17-32-50(7)33-18-34-51(8)35-19-36-52(9)37-20-38-53(10)39-21-40-54(11)41-22-42-55(12)43-44-59-60(56,57)58/h23,25,27,29,31,33,35,37,39,41,43H,13-22,24,26,28,30,32,34,36,38,40,42,44H2,1-12H3,(H2,56,57,58)/b46-25+,47-27+,48-29+,49-31-,50-33+,51-35-,52-37+,53-39+,54-41+,55-43+ | 別名: | Undecaprenyl phosphate | 定義日: | 2015-11-30 | 最終更新日: | 2021-03-01 | 公開日: | 2016-02-17 | 識別子(ID): | [(2~{E},6~{E},10~{E},14~{E},18~{Z},22~{E},26~{Z},30~{E},34~{E},38~{E})-3,7,11,15,19,23,27,31,35,39,43-undecamethyltetratetraconta-2,6,10,14,18,22,26,30,34,38,42-undecaenyl] dihydrogen phosphate |
|
![SWH SWH](https://data.pdbj.org/pdbjplus/data/cc/svg/SWH.svg) | SWH | 表記: | {4-[(4-{(Z)-[3-(4-FLUOROBENZYL)-2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE]METHYL}PHENOXY)METHYL]PHENYL}(TRIHYDROXY)BORATE(1-) | 組成式: | C24 H20 B F N O6 S | SMILES: | O=C1S/C(C(=O)N1Cc2ccc(F)cc2)=Cc4ccc(OCc3ccc(cc3)[B-](O)(O)O)cc4 | InChi: | InChI=1S/C24H20BFNO6S/c26-20-9-3-17(4-10-20)14-27-23(28)22(34-24(27)29)13-16-5-11-21(12-6-16)33-15-18-1-7-19(8-2-18)25(30,31)32/h1-13,30-32H,14-15H2/q-1/b22-13- | 別名: | HA155 INHIBITOR | 定義日: | 2010-09-14 | 最終更新日: | 2021-03-01 | 識別子(ID): | {4-[(4-{(Z)-[3-(4-fluorobenzyl)-2,4-dioxo-1,3-thiazolidin-5-ylidene]methyl}phenoxy)methyl]phenyl}(trihydroxy)borate(1-) |
|
![TBH TBH](https://data.pdbj.org/pdbjplus/data/cc/svg/TBH.svg) | TBH | 表記: | 5-(2-{2-[(TERT-BUTOXY-HYDROXY-METHYL)-AMINO]-1-HYDROXY-3-PHENYL-PROPYLAMINO}-3-HYDROXY-3-PENTYLAMINO-PROPYL)-2-CARBOXYMETHOXY-BENZOIC ACID | 組成式: | C31 H47 N3 O9 | SMILES: | O=C(O)c1cc(ccc1OCC(=O)O)CC(NC(O)C(NC(O)OC(C)(C)C)Cc2ccccc2)C(O)NCCCCC | InChi: | InChI=1S/C31H47N3O9/c1-5-6-10-15-32-27(37)23(18-21-13-14-25(42-19-26(35)36)22(16-21)29(39)40)33-28(38)24(17-20-11-8-7-9-12-20)34-30(41)43-31(2,3)4/h7-9,11-14,16,23-24,27-28,30,32-34,37-38,41H,5-6,10,15,17-19H2,1-4H3,(H,35,36)(H,39,40)/t23-,24-,27+,28-,30-/m0/s1 | 別名: | PNU177836 | 定義日: | 2001-06-26 | 最終更新日: | 2021-03-01 | 識別子(ID): | 5-[(2S,3R)-2-{[(1S,2S)-2-{[(S)-tert-butoxy(hydroxy)methyl]amino}-1-hydroxy-3-phenylpropyl]amino}-3-hydroxy-3-(pentylamino)propyl]-2-(carboxymethoxy)benzoic acid |
|
![ROF ROF](https://data.pdbj.org/pdbjplus/data/cc/svg/ROF.svg) | ROF | 表記: | 3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE | 組成式: | C17 H14 Cl2 F2 N2 O3 | SMILES: | Clc3c(NC(=O)c2ccc(OC(F)F)c(OCC1CC1)c2)c(Cl)cnc3 | InChi: | InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24) | 別名: | ROFLUMILAST | 定義日: | 2004-11-16 | 最終更新日: | 2021-03-01 | 識別子(ID): | 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide |
|
![QVV QVV](https://data.pdbj.org/pdbjplus/data/cc/svg/QVV.svg) | QVV | 表記: | benzyl [2-(4-{[2-(6-amino-9H-purin-9-yl)ethyl]carbamoyl}-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]carbamate | 組成式: | C23 H25 N9 O5 | SMILES: | CC(C)(NC(OCc1ccccc1)=O)C2=NC(=C(C(N2)=O)O)C(NCCn4c3ncnc(c3nc4)N)=O | InChi: | InChI=1S/C23H25N9O5/c1-23(2,31-22(36)37-10-13-6-4-3-5-7-13)21-29-14(16(33)20(35)30-21)19(34)25-8-9-32-12-28-15-17(24)26-11-27-18(15)32/h3-7,11-12,33H,8-10H2,1-2H3,(H,25,34)(H,31,36)(H2,24,26,27)(H,29,30,35) | 別名: | SJ000988248 | 定義日: | 2020-01-02 | 最終更新日: | 2021-03-01 | 公開日: | 2021-02-10 | 識別子(ID): | benzyl [2-(4-{[2-(6-amino-9H-purin-9-yl)ethyl]carbamoyl}-5-hydroxy-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]carbamate |
|
![NZH NZH](https://data.pdbj.org/pdbjplus/data/cc/svg/NZH.svg) | NZH | 表記: | (2S)-2-AMINO-3-[1-(1H-TETRAAZOL-5-YL)-1H-IMIDAZOL-4-YL]PROPANAL | 組成式: | C7 H9 N7 O | SMILES: | O=CC(N)Cc2ncn(c1nnnn1)c2 | InChi: | InChI=1S/C7H9N7O/c8-5(3-15)1-6-2-14(4-9-6)7-10-12-13-11-7/h2-5H,1,8H2,(H,10,11,12,13)/t5-/m0/s1 | 別名: | TETRAZOLYL HISTIDINE | 定義日: | 2004-12-28 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2S)-2-amino-3-[1-(1H-tetrazol-5-yl)-1H-imidazol-4-yl]propanal |
|
![TBL TBL](https://data.pdbj.org/pdbjplus/data/cc/svg/TBL.svg) | TBL | 表記: | N-[(4-methoxyphenyl)sulfonyl]-D-alanine | 組成式: | C10 H13 N O5 S | SMILES: | O=C(O)C(NS(=O)(=O)c1ccc(OC)cc1)C | InChi: | InChI=1S/C10H13NO5S/c1-7(10(12)13)11-17(14,15)9-5-3-8(16-2)4-6-9/h3-7,11H,1-2H3,(H,12,13)/t7-/m1/s1 | 別名: | (R)-2-(4-methoxyphenylsulfonamido)propanoic acid | 定義日: | 2008-09-18 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[(4-methoxyphenyl)sulfonyl]-D-alanine |
|
![ZPC ZPC](https://data.pdbj.org/pdbjplus/data/cc/svg/ZPC.svg) | ZPC | 表記: | (5R)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate | 組成式: | C17 H17 Cl N6 O3 | SMILES: | O=C(OC3c1nccnc1C(=O)N3c2ncc(Cl)cc2)N4CCN(C)CC4 | InChi: | InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m1/s1 | 別名: | R-ZOPICLONE | 定義日: | 2011-11-25 | 最終更新日: | 2021-03-01 | 公開日: | 2012-10-12 | 識別子(ID): | (5R)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate |
|
![TBQ TBQ](https://data.pdbj.org/pdbjplus/data/cc/svg/TBQ.svg) | TBQ | 表記: | (3~{R})-1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol | 組成式: | C16 H22 Cl N3 O | SMILES: | CC(C)(C)[C](O)(CCc1ccc(Cl)cc1)Cn2cncn2 | InChi: | InChI=1S/C16H22ClN3O/c1-15(2,3)16(21,10-20-12-18-11-19-20)9-8-13-4-6-14(17)7-5-13/h4-7,11-12,21H,8-10H2,1-3H3/t16-/m0/s1 | 別名: | (R)-tebuconazole | 定義日: | 2015-10-20 | 最終更新日: | 2021-03-01 | 公開日: | 2016-02-10 | 識別子(ID): | (3~{R})-1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol |
|
![TBR TBR](https://data.pdbj.org/pdbjplus/data/cc/svg/TBR.svg) | TBR | 表記: | HEXATANTALUM DODECABROMIDE | 組成式: | Br12 Ta6 | SMILES: | Br|1[Ta]|2|3|4|5|Br[Ta]|6|7|89%10|2|Br[Ta]|%11|%12|%13|%14|1|3|6Br|[Ta]|%15|%16|%17|7|%11(Br|[Ta]|%18|4|%12|%15(Br|%13)(Br|%14)|Br[Ta]|5|8|%16|%18(|Br9)(Br)Br|%17)|Br%10 | InChi: | InChI=1S/12BrH.6Ta/h12*1H | 別名: | DODECABROMOHEXATANTALUM | 定義日: | 1999-11-12 | 最終更新日: | 2021-03-01 |
|
![ZPH ZPH](https://data.pdbj.org/pdbjplus/data/cc/svg/ZPH.svg) | ZPH | 表記: | methyl (2S)-2-{[(R)-[(1R)-1-amino-3-methylbutyl](hydroxy)phosphoryl]oxy}-3-phenylpropanoate | 組成式: | C15 H24 N O5 P | SMILES: | O=C(OC)C(OP(=O)(O)C(N)CC(C)C)Cc1ccccc1 | InChi: | InChI=1S/C15H24NO5P/c1-11(2)9-14(16)22(18,19)21-13(15(17)20-3)10-12-7-5-4-6-8-12/h4-8,11,13-14H,9-10,16H2,1-3H3,(H,18,19)/t13-,14+/m0/s1 | 別名: | LP(0)PHEOMe | 定義日: | 2010-10-22 | 最終更新日: | 2021-03-01 | 識別子(ID): | methyl (2S)-2-{[(R)-[(1R)-1-amino-3-methylbutyl](hydroxy)phosphoryl]oxy}-3-phenylpropanoate |
|
![ROS ROS](https://data.pdbj.org/pdbjplus/data/cc/svg/ROS.svg) | ROS | 表記: | N,N'-TETRAMETHYL-ROSAMINE | 組成式: | C23 H23 N2 O | SMILES: | O2c1cc(ccc1C(=C3C2=CC(=[N+](/C)C)C=C3)c4ccccc4)N(C)C | InChi: | InChI=1S/C23H23N2O/c1-24(2)17-10-12-19-21(14-17)26-22-15-18(25(3)4)11-13-20(22)23(19)16-8-6-5-7-9-16/h5-15H,1-4H3/q+1 | 別名: | (6-DIMETHYLAMINO-9-PHENYL-XANTHEN-3-YLIDENE)-DIMETHYL-AMMONIUM | 定義日: | 2000-05-22 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-[6-(dimethylamino)-9-phenyl-3H-xanthen-3-ylidene]-N-methylmethanaminium |
|
![ZPN ZPN](https://data.pdbj.org/pdbjplus/data/cc/svg/ZPN.svg) | ZPN | 表記: | (2Z,4E)-N-[(S)-[(1S,2E,5S,8E,10Z,17S)-3,11-dimethyl-19-methylidene-7,13-dioxo-6,21-dioxabicyclo[15.3.1]henicosa-2,8,10-trien-5-yl](hydroxy)methyl]hexa-2,4-dienamide | 組成式: | C29 H39 N O6 | SMILES: | O=C(/C=CC=CC)NC(O)C1OC(=O)C=CC=C(CC(=O)CCCC2OC(C=C(C)C1)CC(=C)/C2)C | InChi: | InChI=1S/C29H39NO6/c1-5-6-7-13-27(32)30-29(34)26-19-22(4)18-25-17-21(3)16-24(35-25)12-9-11-23(31)15-20(2)10-8-14-28(33)36-26/h5-8,10,13-14,18,24-26,29,34H,3,9,11-12,15-17,19H2,1-2,4H3,(H,30,32)/b6-5+,13-7-,14-8+,20-10-,22-18+/t24-,25-,26-,29-/m0/s1 | 別名: | (-)-ZAMPANOLIDE (Bound form) | 定義日: | 2012-12-20 | 最終更新日: | 2021-03-01 | 公開日: | 2013-01-18 | 識別子(ID): | (2Z,4E)-N-[(S)-[(1S,2E,5S,8E,10Z,17S)-3,11-dimethyl-19-methylidene-7,13-dioxo-6,21-dioxabicyclo[15.3.1]henicosa-2,8,10-trien-5-yl](hydroxy)methyl]hexa-2,4-dienamide |
|
![WR7 WR7](https://data.pdbj.org/pdbjplus/data/cc/svg/WR7.svg) | WR7 | 表記: | 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl [(1R)-2,2,2-trichloro-1-(pyrimidin-2-ylamino)ethyl]carbamate | 組成式: | C13 H14 Cl3 N7 O4 | SMILES: | ClC(Cl)(Cl)C(Nc1ncccn1)NC(=O)OCCn2c(cnc2C)[N+]([O-])=O | InChi: | InChI=1S/C13H14Cl3N7O4/c1-8-19-7-9(23(25)26)22(8)5-6-27-12(24)21-10(13(14,15)16)20-11-17-3-2-4-18-11/h2-4,7,10H,5-6H2,1H3,(H,21,24)(H,17,18,20)/t10-/m1/s1 | 別名: | apcin | 定義日: | 2013-10-22 | 最終更新日: | 2021-03-01 | 公開日: | 2014-08-20 | 識別子(ID): | 2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl [(1R)-2,2,2-trichloro-1-(pyrimidin-2-ylamino)ethyl]carbamate |
|
![ZPR ZPR](https://data.pdbj.org/pdbjplus/data/cc/svg/ZPR.svg) | ZPR | 表記: | N-BENZYLOXYCARBONYL-L-PROLYL-L-PROLINAL | 組成式: | C18 H22 N2 O4 | SMILES: | O=C(N1C(C=O)CCC1)C3N(C(=O)OCc2ccccc2)CCC3 | InChi: | InChI=1S/C18H22N2O4/c21-12-15-8-4-10-19(15)17(22)16-9-5-11-20(16)18(23)24-13-14-6-2-1-3-7-14/h1-3,6-7,12,15-16H,4-5,8-11,13H2/t15-,16-/m0/s1 | 別名: | Z-PRO-PROLINAL | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | benzyl (2S)-2-{[(2S)-2-formylpyrrolidin-1-yl]carbonyl}pyrrolidine-1-carboxylate |
|
![W8R W8R](https://data.pdbj.org/pdbjplus/data/cc/svg/W8R.svg) | W8R | 表記: | 5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE | 組成式: | C21 H28 N2 O3 | SMILES: | N1=C(OCC1C)c3ccc(OCCCCCCCc2onc(c2)C)cc3 | InChi: | InChI=1S/C21H28N2O3/c1-16-14-20(26-23-16)8-6-4-3-5-7-13-24-19-11-9-18(10-12-19)21-22-17(2)15-25-21/h9-12,14,17H,3-8,13,15H2,1-2H3/t17-/m1/s1 | 別名: | COMPOUND I(R) | 定義日: | 1999-07-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | 3-methyl-5-(7-{4-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]phenoxy}heptyl)isoxazole |
|
![VDM VDM](https://data.pdbj.org/pdbjplus/data/cc/svg/VDM.svg) | VDM | 表記: | (1S,2S,3R,6S)-4-(HYDROXYMETHYL)-6-{[(1S,2S,3S,4R,5R)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL]AMINO}CYCLOHEX-4-ENE-1,2,3-TRIOL | 組成式: | C14 H25 N O8 | SMILES: | OC2C(NC1C=C(CO)C(O)C(O)C1O)CC(C(O)C2O)CO | InChi: | InChI=1S/C14H25NO8/c16-3-5-1-7(11(20)13(22)9(5)18)15-8-2-6(4-17)10(19)14(23)12(8)21/h1,6-23H,2-4H2/t6-,7+,8+,9-,10-,11+,12+,13+,14+/m1/s1 | 別名: | VALIDOXYLAMINE | 定義日: | 2007-01-25 | 最終更新日: | 2021-03-01 | 識別子(ID): | (1S,2S,3R,6S)-4-(hydroxymethyl)-6-{[(1S,2S,3S,4R,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}cyclohex-4-ene-1,2,3-triol |
|
![SIP SIP](https://data.pdbj.org/pdbjplus/data/cc/svg/SIP.svg) | SIP | 表記: | 8-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | 組成式: | C23 H26 F N3 O2 | SMILES: | Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4 | InChi: | InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29) | 別名: | Spiperone | 定義日: | 2017-08-08 | 最終更新日: | 2021-03-01 | 公開日: | 2020-12-30 | 識別子(ID): | 8-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one |
|
![SIS SIS](https://data.pdbj.org/pdbjplus/data/cc/svg/SIS.svg) | SIS | 表記: | (1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside | 組成式: | C19 H37 N5 O7 | SMILES: | O(C2C(O)C(OC1OC(=CCC1N)CN)C(N)CC2N)C3OCC(O)(C(NC)C3O)C | InChi: | InChI=1S/C19H37N5O7/c1-19(27)7-28-18(13(26)16(19)24-2)31-15-11(23)5-10(22)14(12(15)25)30-17-9(21)4-3-8(6-20)29-17/h3,9-18,24-27H,4-7,20-23H2,1-2H3/t9-,10+,11-,12+,13-,14-,15+,16-,17-,18-,19+/m1/s1 | 別名: | Sisomicin | 定義日: | 2012-06-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | (1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside |
|
![VDY VDY](https://data.pdbj.org/pdbjplus/data/cc/svg/VDY.svg) | VDY | 表記: | 3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL | 組成式: | C27 H44 O2 | SMILES: | OC3CC(=C/C=C1CCCC2(C)C(C(C)CCCC(O)(C)C)CCC12)/C(=C)CC3 | InChi: | InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1 | 別名: | 25-HYDROXYVITAMIN D3 | 定義日: | 2001-05-18 | 最終更新日: | 2021-03-01 | 識別子(ID): | (3S,5Z,14beta,17alpha)-9,10-secocholesta-5,7,10-triene-3,25-diol |
|
![RPG RPG](https://data.pdbj.org/pdbjplus/data/cc/svg/RPG.svg) | RPG | 表記: | (13E,15S)-15-hydroxy-9-oxoprosta-10,13-dien-1-oic acid | 組成式: | C20 H32 O4 | SMILES: | CCCCC[CH](O)C=C[CH]1C=CC(=O)[CH]1CCCCCCC(O)=O | InChi: | InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/b14-12+/t16-,17-,18+/m0/s1 | 別名: | PROSTAGLANDIN A1 (PGA1) | 定義日: | 2017-08-17 | 最終更新日: | 2021-03-01 | 公開日: | 2018-12-26 | 識別子(ID): | 7-[(1~{R},5~{S})-2-oxidanylidene-5-[(~{E},3~{S})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]heptanoic acid |
|
![TCE TCE](https://data.pdbj.org/pdbjplus/data/cc/svg/TCE.svg) | TCE | 表記: | 3,3',3''-phosphanetriyltripropanoic acid | 組成式: | C9 H15 O6 P | SMILES: | O=C(O)CCP(CCC(=O)O)CCC(=O)O | InChi: | InChI=1S/C9H15O6P/c10-7(11)1-4-16(5-2-8(12)13)6-3-9(14)15/h1-6H2,(H,10,11)(H,12,13)(H,14,15) | 別名: | 3-[bis(2-carboxyethyl)phosphanyl]propanoic acid | 定義日: | 2009-01-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | 3,3',3''-phosphanetriyltripropanoic acid |
|